IV Bags Market is projected to grow at a CAGR of 6.13% to reach US$5.467 billion in 2029

The IV bags market is expected to grow at a CAGR of 6.13% during the forecasted period, with a market valuation of US$4.061 billion in 2024, and is expected to reach US$5.467 billion by 2029.

Intravenous or IV bags are used in healthcare settings, to monitor the fluids, nutrients, or medication, that are directed toward the bloodstream of the patients. IV bags are used for the treatment of multiple diseases, from common illnesses, and weakness to chronic diseases and cancers. The IV therapy helps with hydrating the patient's body, along with enhancing immunity, boosting energy levels, and detoxification of the body.

The IV bag industry is sure to witness a significant boost with the rising cases of diseases, and increasing public perception towards better healthcare services. Various companies and organizations have introduced multiple products to attract a greater market share, for instance, in July 2024, Amneal Pharmaceuticals, Inc. announced that the company achieved the New Drug Application (NDA) approval from the Food and Drug Administration (FDA) of the USA, for its sodium chloride injection intravenous (IV) ready-to-use (RTU) bags. Similarly, in June 2022, the global pharmaceutical product manufacturer, Gufic Biosciences launched its New Drug Delivery System: Dual Chamber Bags, which aims to attain maximum share in the nation's antibiotic antifungal market.

The material type segment of the IV bags market is categorized into PVC, PP, and PE. Under the material type segment of the IV bags market, the PVC material category is forecasted to attain a greater market share. The PVC IV bags are made using polymerization of vinyl chloride material, and it offer cheaper and more durable products. The PVC IV bags are commonly used across major healthcare organizations, across the globe, as it is impermeable to germs, and can easily be cleaned. It also provides a single-use application which helps in reducing the risk of infections in the hospitals.

The IV bags market, by capacity, is segmented into less than 100 ml, 100-250 ml, 250-500 ml, 500-1000 ml, and above 1000 ml. In the capacity category of the IV bags market, the 250-500 ml category is estimated to attain the maximum market share in the global market. The 250-500 ml capacity of the IV bags in the IV bags market is also used across multiple diseases, like as chemotherapy for cancer cases.

The chamber type segment of the IV bags market is categorized into single-chamber and multi-chamber. The multi-chamber IV bags under the chamber type segment of the IV bags market are estimated to attain a greater market share during the forecasted year. The multi-chamber type IV bags can be used to contain multiple fluids or medications. The multi-chamber bags generally use a high oxygen barrier, protecting against oxidation. The multi-chamber IV bags reduce the handling of the medication, and reduce the risk of contamination of the mixer fluids.

The IV bags market, by end-user, is segmented into blood banks, hospitals, and ambulatory services. Under the end-user segment of the IV bags market, the hospital category is estimated to attain a greater market share during the forecasted timeline. In hospitals, IV bags have multiple applications, for instance, during kidney dialysis procedures, chemotherapy, or during general treatment of any patients. The hospital category also witnesses a greater footfall of patients as compared to the blood banks, and ambulatory services. Furthermore, various developing nations, like India, Bangladesh, Vietnam, and Indonesia have announced multiple projects, incentives, and policies to boost their hospital infrastructure, which is estimated to boost the demand for IV bags in the hospital category of the end-user segment.

Based on geography, the Asia Pacific region of the IV bags market is expected to grow significantly, as the region offers a growing healthcare infrastructure and industry. Countries like India, China, Japan, Taiwan, and Malaysia are among the biggest producers of medical products in the globe. The government in the region like India, Japan, China, and Malaysia also introduces multiple incentives and subsidies to boost the growth of the medical infrastructure in the region.

The research includes several key players from the IV bags market, such as Sippex, Kraton Corporation, Renolit Solmed, Alfa Laboratories, Polycine GmbH, Haemotronic S.P.A., Hospira Inc., Technoflex S.A., The Metrix Company, Medicopack A/S, Wipak Group, and Qosina Corporation.

View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/iv-bags-market

This analytics report segments the hair growth supplements market as follows:

• By Material Type
  • PVC
  • PP
  • PE
• By Capacity
  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml
• By Chamber Type
  • Single Chamber
  • Multi Chamber
• By End-User
  • Blood Banks
  • Hospitals
  • Ambulatory Services
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Indonesia
    • Others
• Aseptic Packaging Market Size
• Global Pharmaceutical Packaging Market Trends
• Plastic Healthcare Packaging Market Size